NEW YORK, March 15 /PRNewswire/ -- On March 12, Dr. Mechael Kanovsky, CEO of Amazon Biotech, Inc. (OTC:AMZB) (BULLETIN BOARD: AMZB) updated the investment community in an all-new interview with http://www.wallst.net/. Interview highlights include detailed discussions on the following topics: - the company's lead drug candidate
- targeting HIV and AIDS patients with the company's drug candidate
- reasons the company is in a "unique position"
- how the company's drug candidate "helps the body help itself"
- reasons the company has a competitive edge
- upcoming clinical developments for investors to watch for To hear the interview in its entirety, and to read an in-depth report on the company, visit http://www.wallst.net/superstocks/superstocks_profile.asp?ticker=amzb.
On February 26, Mark Julien, Chief Financial Officer of Kronos, Inc. (NASDAQ:KRON) updated the investment community in an all-new interview with http://www.wallst.net/. Interview highlights include detailed discussions on the following topics: - how the company's solutions help organizations "reduce costs, increase
productivity, improve employee satisfaction, and ultimately enhance the level of service employees provide"
- key drivers behind the company's first quarter revenue growth
- establishing a broader footprint in the talent management market
- the company's global strategy
- industry trends bolstering the company's near-term growth prospects
- upcoming milestones for investors to watch for To hear the interview in its entirety, and to read an in-depth article on the company, visit http://wallst.net/editorials/article.asp?id=648.
On March 9, Gokul Hemmady, Chief Financial Officer of ADC Telecommunications, Inc. (NASDAQ:ADCT) updated the investment community in an all-new interview with http://www.wallst.net/. Interview highlights include detailed discussions on the following topics: - key drivers behind the company's first-quarter revenue growth
- key drivers behind the company's sequential improvement in gross
margins
- earnings guidance for the full year
- reasons the company is "very well positioned" in many of its target
markets
- consolidation trends among the company's customers
- upcoming milestones for investors to watch for To hear the interview in its entirety, visit http://wallst.net/audio/audio.asp?symbol=ADCT&id=3138.
About WallSt.net: http://www.wallst.net/ is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The website is a leading provider of financial news, media, tools and community-driven applications for investors. http://www.wallst.net/ offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies. We are expecting to receive three thousand two hundred fifty dollars from Amazon Biotech, Inc. for media and advertising services. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp .
(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO) http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO http://photoarchive.ap.org/ DATASOURCE: WallStreet Direct, Inc.
CONTACT: Nick Iyer of Digital Wall Street, Inc., +1-800-4-WALL-ST Web site: http://www.wallst.net/
|